 Hypoglycemic Agents
"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances which lower blood glucose levels.
| Descriptor ID |
D007004
|
| MeSH Number(s) |
D27.505.696.422
|
| Concept/Terms |
Hypoglycemic Agents- Hypoglycemic Agents
- Agents, Hypoglycemic
- Hypoglycemics
- Hypoglycemic Drugs
- Drugs, Hypoglycemic
- Antihyperglycemic Agents
- Agents, Antihyperglycemic
- Antihyperglycemics
Hypoglycemic Effect- Hypoglycemic Effect
- Effect, Hypoglycemic
- Hypoglycemic Effects
- Effects, Hypoglycemic
Antidiabetics- Antidiabetics
- Antidiabetic Drugs
- Drugs, Antidiabetic
- Antidiabetic Agents
- Agents, Antidiabetic
|
Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".
Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".
This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 0 | 1 | | 1995 | 1 | 1 | 2 | | 1996 | 1 | 0 | 1 | | 1997 | 3 | 4 | 7 | | 1998 | 2 | 3 | 5 | | 1999 | 0 | 2 | 2 | | 2000 | 4 | 3 | 7 | | 2001 | 1 | 3 | 4 | | 2002 | 4 | 2 | 6 | | 2003 | 4 | 2 | 6 | | 2004 | 5 | 4 | 9 | | 2005 | 5 | 3 | 8 | | 2006 | 7 | 4 | 11 | | 2007 | 4 | 6 | 10 | | 2008 | 6 | 3 | 9 | | 2009 | 4 | 7 | 11 | | 2010 | 6 | 6 | 12 | | 2011 | 4 | 5 | 9 | | 2012 | 3 | 4 | 7 | | 2013 | 10 | 8 | 18 | | 2014 | 12 | 8 | 20 | | 2015 | 14 | 7 | 21 | | 2016 | 10 | 7 | 17 | | 2017 | 11 | 6 | 17 | | 2018 | 6 | 12 | 18 | | 2019 | 8 | 11 | 19 | | 2020 | 3 | 7 | 10 | | 2021 | 0 | 11 | 11 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.
-
Miller KM, Kanapka LG, Rickels MR, Ahmann AJ, Aleppo G, Ang L, Bhargava A, Bode BW, Carlson A, Chaytor NS, Gannon G, Goland R, Hirsch IB, Kiblinger L, Kruger D, Kudva YC, Levy CJ, McGill JB, O'Malley G, Peters AL, Philipson LH, Philis-Tsimikas A, Pop-Busui R, Salam M, Shah VN, Thompson MJ, Vendrame F, Verdejo A, Weinstock RS, Young L, Pratley R. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes. Diabetes Technol Ther. 2022 06; 24(6):424-434.
-
Handelsman Y, Anderson JE, Bakris GL, Ballantyne CM, Beckman JA, Bhatt DL, Bloomgarden ZT, Bozkurt B, Budoff MJ, Butler J, Dagogo-Jack S, de Boer IH, DeFronzo RA, Eckel RH, Einhorn D, Fonseca VA, Green JB, Grunberger G, Guerin C, Inzucchi SE, Jellinger PS, Kosiborod MN, Kushner P, Lepor N, Mende CW, Michos ED, Plutzky J, Taub PR, Umpierrez GE, Vaduganathan M, Weir MR. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2022 02; 36(2):108101.
-
Sun X, Rashid M, Hobbs N, Brandt R, Askari MR, Cinar A. Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems. J Diabetes Sci Technol. 2022 Jan; 16(1):19-28.
-
Lee CG, Heckman-Stoddard B, Dabelea D, Gadde KM, Ehrmann D, Ford L, Prorok P, Boyko EJ, Pi-Sunyer X, Wallia A, Knowler WC, Crandall JP, Temprosa M. Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care. 2021 12; 44(12):2775-2782.
-
Alexander JT, Staab EM, Wan W, Franco M, Knitter A, Skandari MR, Bolen S, Maruthur NM, Huang ES, Philipson LH, Winn AN, Thomas CC, Zeytinoglu M, Press VG, Tung EL, Gunter K, Bindon B, Jumani S, Laiteerapong N. The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
-
Blitzer AL, Ham SA, Skondra D. Methodological Considerations for the Case-Control Study of Metformin and Age-Related Macular Degeneration-Reply. JAMA Ophthalmol. 2021 08 01; 139(8):919-920.
-
Sevil M, Rashid M, Hajizadeh I, Park M, Quinn L, Cinar A. Physical Activity and Psychological Stress Detection and Assessment of Their Effects on Glucose Concentration Predictions in Diabetes Management. IEEE Trans Biomed Eng. 2021 07; 68(7):2251-2260.
-
Brandt R, Park M, Wroblewski K, Quinn L, Tasali E, Cinar A. Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetes. Diabetologia. 2021 10; 64(10):2159-2169.
-
Huang ES, Lipska KJ. The Cost and Safety of Insulin in Older Adults. JAMA Intern Med. 2021 05 01; 181(5):608-609.
-
Pham CH, Vrouwe SQ, Tsai K, Ding L, Collier ZJ, Grote AC, Angell TE, Garner WL, Gillenwater TJ, Yenikomshian HA. Hypoglycemic episodes predict length of stay in patients with acute burns. J Crit Care. 2021 08; 64:68-73.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|